CRDL Cardiol Therapeutics Inc

Life Sciences Investor Forum today announced that the presentations from the September 17th conference are now available for on-demand viewing at LifeSciencesInvestorForum.com.

This virtual event showcased live company presentations and interactive discussions focused on the life sciences industry. The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download shareholder materials from the company’s “virtual trade booth”.

REGISTER OR LOGIN AT:  https://bit.ly/3m5MTfY

September 17th Presenting Companies:

Company Name	Ticker(s)
Starpharma Holdings Ltd.	OTCQX: SPHRY | ASX: SPL
VolitionRx Limited	NYSE AMERICAN: VNRX
KemPharm, Inc.	OTCQB: KMPH
Assure Holdings Corp.	OTCQB: ARHH | TSX-V: IOM
aTyr Pharma, Inc.	Nasdaq: LIFE
SWK Holdings, Inc	Nasdaq: SWKH
Cardiol Therapeutics Inc.	OTCQX: CRTPF | TSX: CRDL
XPhyto Therapeutics Corp.	OTCQB: XPHYF | CSE: XPHY | FSE: 4XT
Nuvo Pharmaceuticals Inc.	OTCQX: NRIFF | TSX: NRI
Salarius Pharmaceuticals, Inc.	Nasdaq: SLRX
Willow Biosciences Inc.	OTCQB: CANSF | TSX: WLLW
Orexo AB	OTCQX: ORXOY | Nasdaq STO: ORX
Caladrius Biosciences, Inc.	Nasdaq: CLBS
Kineta, Inc	Private Company
Sixth Wave Innovations Inc.	OTCQB: ATURF | CSE: SIXW | FSE: AHUH

To facilitate investor relations scheduling and for more information about the program, please visit www.lifesciencesinvestorforum.com.

About Life Sciences Investor ForumLife Sciences Investor Forum is the leading proprietary investor conference series that provides an interactive forum for Life Sciences companies to meet with and present directly to investors.

A real-time solution for investor engagement, Life Sciences Investor Forum is powered by Intrado Digital Media and specifically designed for more efficient investor access. Replicating the look and feel of on-site investor conferences, Life Sciences Investor Forum combines leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.

CONTACTLife Sciences Investor ForumJohn M. ViglottiSVP Corporate Services, Investor Access(212) 220-2221johnv@lifesciencesinvestorforum.com